A recently developed technology could help in restore the sight of the blind and at the same time stop others from losing their sight when one is being examined on people for the first time.

Authors seemingly have given a green light to infuse embryonic stem cells into the eyes of teenagers and young men and women with a hereditary form of blindness.

Tests performed on older subjects with age concerned macular degeneration (AMD), the most usual form of blindness in the elderly, will soon be featured in the coming year.

Although the first trials will be done in US, British trials will soon be following the path. The virus replicates the ‘phenomenol’ outcomes of animal testing, and also the lives of millions could be changed all throughout.

However the usage of cells comes in initial days of embryo development is a subject of controversy, with pro-life group claiming it to be wrong with an ability of unborn baby to come appear in medical science.

Robert Lanza, a leading stem cell researcher, will proclaim the granted permission to reach out for the world’s first trial into the power of embryonic stem cells to heal the eye.

Dr Lanza, of Massachusetts biotech firm Advanced Cell Technology, said, ‘He will apply for permission to carry out trials on Britons with eye disease. This is a huge milestone for us.’